Klein Joseph III
Director at IONS; Director at BMRN; Director at PROTEIN DESIGN LABS INC/DE, and 4 more
- Sold, on record
- $19.5M
- Dollars the filings state
- Form 4 sales
- 56
- Latest Jul 1, 2026
- Form 144 notices
- 9
- Proposed sales
- Companies
- 7
- Filed as an executive or holder
Companies
- IONSIONIS PHARMACEUTICALS INCDirector
- BMRNBIOMARIN PHARMACEUTICAL INCDirector
- PROTEIN DESIGN LABS INC/DEDirector
- OSI PHARMACEUTICALS INCDirector
- SAVIENT PHARMACEUTICALS INCDirector
- NPS PHARMACEUTICALS INCOther
- CLINICAL DATA INCOther
Sales by reason
7
Routine
21
Plan not stated
1
No plan
27
Unusual
Form 4 sales per year, every sale on record.
Sales by company
- IONS329,893 shares
- BMRN52,000 shares
- NPS PHARMACEUTICALS INC38,100 shares
- SAVIENT PHARMACEUTICALS INC24,000 shares
- PROTEIN DESIGN LABS INC/DE24,000 shares
- OSI PHARMACEUTICALS INC21,250 shares
- CLINICAL DATA INC5,971 shares
Shares sold, every Form 4 sale on record.
Timeline
- Jul 1, 2026Routine
Sold 51.1% of their holdings
$910k11,518 shares at $79.04
- Jul 1, 2026Notice
Filed a notice to sell 11,518 shares
$910k11,518 shares
- May 1, 2026Routine
Sold 47.9% of their holdings
$743k10,111 shares at $73.51
- Apr 1, 2026Routine
Sold 67% of their holdings
$1.7M22,321 shares at $75.54
- Mar 3, 2026Routine
Sold 65.9% of their holdings
$1.7M21,332 shares at $79.51
- Mar 3, 2026Notice
Filed a notice to sell 65,345 shares
$5M65,345 shares
- Nov 25, 2025Routine
Sold 100% of their holdings
$960k12,000 shares at $80.00
- Nov 25, 2025Notice
Filed a notice to sell 12,000 shares
$960k12,000 shares
- Sep 3, 2025Unusual
Sold 100% of their holdings
$1.7M28,000 shares at $60.00
- Sep 3, 2025Unusual
Sold 100% of their holdings
$1.7M28,000 shares at $60.00
10 of 65
Every transaction
| Traded | Filed | Stock | Role | What | Amount | Price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|---|---|
| Jul 1, 2026 | Jul 6, 2026 | IONS | Director | Sold | 11,518 | $79.04 | $910k | 11,014 | SEC |
| Jul 1, 2026 | Jul 6, 2026 | IONS | Director | Exercised or settledNon-Qualified Stock Option (right to buy) | 11,518 | 0 | SEC | ||
| Jul 1, 2026 | Jul 6, 2026 | IONS | Director | Exercised options | 11,518 | $39.94 | $460k | 22,532 | SEC |
| Jul 1, 2026 | Jul 6, 2026 | IONS | Director | AwardedNon-Qualified Stock Option (right to buy) | 7,670 | 16,277 | SEC | ||
| May 1, 2026 | May 5, 2026 | IONS | Director | Sold | 10,111 | $73.51 | $743k | 11,014 | SEC |
| May 1, 2026 | May 5, 2026 | IONS | Director | Exercised or settledNon-Qualified Stock Option (right to buy) | 10,111 | 0 | SEC | ||
| May 1, 2026 | May 5, 2026 | IONS | Director | Exercised options | 10,111 | $47.11 | $476k | 21,125 | SEC |
| Apr 1, 2026 | Apr 2, 2026 | IONS | Director | Sold | 22,321 | $75.54 | $1.7M | 11,014 | SEC |
| Apr 1, 2026 | Apr 2, 2026 | IONS | Director | Exercised or settledNon-Qualified Stock Option (right to buy) | 22,321 | 0 | SEC | ||
| Apr 1, 2026 | Apr 2, 2026 | IONS | Director | Exercised options | 22,321 | $39.46 | $881k | 33,335 | SEC |
| Mar 3, 2026 | Mar 5, 2026 | IONS | Director | Sold | 21,332 | $79.51 | $1.7M | 11,014 | SEC |
| Mar 3, 2026 | Mar 5, 2026 | IONS | Director | Exercised or settledNon-Qualified Stock Option (right to buy) | 16,000 | 0 | SEC | ||
| Mar 3, 2026 | Mar 5, 2026 | IONS | Director | Exercised options | 16,000 | $40.76 | $652k | 32,346 | SEC |
| Nov 25, 2025 | Nov 28, 2025 | IONS | Director | Sold | 12,000 | $80.00 | $960k | 0 | SEC |
| Nov 25, 2025 | Nov 28, 2025 | IONS | Director | Exercised or settledNon-Qualified Stock Option (right to buy) | 12,000 | 0 | SEC | ||
| Nov 25, 2025 | Nov 28, 2025 | IONS | Director | Exercised options | 12,000 | 4,000 | SEC | ||
| Sep 3, 2025 | Sep 4, 2025 | IONS | Director | Sold | 28,000 | $60.00 | $1.7M | 0 | SEC |
| Sep 3, 2025 | Sep 4, 2025 | IONS | Director | Exercised or settledNon-Qualified Stock Option (right to buy) | 28,000 | 0 | SEC | ||
| Sep 3, 2025 | Sep 4, 2025 | IONS | Director | Exercised options | 28,000 | 28,000 | SEC | ||
| Sep 3, 2025 | Sep 4, 2025 | IONS | Director | Sold | 28,000 | $60.00 | $1.7M | 0 | SEC |
| Sep 3, 2025 | Sep 4, 2025 | IONS | Director | Exercised or settledNon-Qualified Stock Option (right to buy) | 28,000 | 0 | SEC | ||
| Sep 3, 2025 | Sep 4, 2025 | IONS | Director | Exercised options | 28,000 | 28,000 | SEC | ||
| Jul 1, 2025 | Jul 2, 2025 | IONS | Director | AwardedNon-Qualified Stock Option (right to buy) | 16,738 | 13,976 | SEC | ||
| Jul 16, 2024 | Jul 17, 2024 | IONS | Director | Sold | 12,000 | $50.00 | $600k | 0 | SEC |
| Jul 16, 2024 | Jul 17, 2024 | IONS | Director | Exercised or settledNon-Qualified Stock Option (right to buy) | 12,000 | 0 | SEC | ||
| Jul 16, 2024 | Jul 17, 2024 | IONS | Director | Exercised options | 12,000 | $24.42 | $293k | 12,000 | SEC |
| Jul 1, 2024 | Jul 3, 2024 | IONS | Director | AwardedNon-Qualified Stock Option (right to buy) | 14,190 | 8,756 | SEC | ||
| May 3, 2024 | May 7, 2024 | IONS | Director | Sold | 6,000 | $42.71 | $256k | 0 | SEC |
| Nov 15, 2023 | Nov 17, 2023 | IONS | Director | Sold | 2,000 | $50.00 | $100k | 16,346 | SEC |
| Sep 26, 2023 | Sep 28, 2023 | IONS | Director | Sold | 2,000 | $45.13 | $90k | 18,346 | SEC |
| Jul 18, 2023 | Jul 19, 2023 | IONS | Director | Sold | 3,555 | $42.00 | $149k | 20,346 | SEC |
| Jul 17, 2023 | Jul 19, 2023 | IONS | Director | Exercised or settledRestricted Stock Unit | 7,110 | 4,677 | SEC | ||
| Jul 17, 2023 | Jul 19, 2023 | IONS | Director | Exercised options | 7,110 | 23,901 | SEC | ||
| Jul 3, 2023 | Jul 6, 2023 | IONS | Director | AwardedNon-Qualified Stock Option (right to buy) | 14,998 | 11,787 | SEC | ||
| Jan 17, 2023 | Jan 18, 2023 | IONS | Director | Sold | 2,000 | $40.00 | $80k | 16,791 | SEC |
| Jul 15, 2022 | Jul 19, 2022 | IONS | Director | Sold | 1,333 | $38.24 | $51k | 18,791 | SEC |
| Jul 15, 2022 | Jul 19, 2022 | IONS | Director | Exercised or settledRestricted Stock Unit | 7,998 | 7,110 | SEC | ||
| Jul 15, 2022 | Jul 19, 2022 | IONS | Director | Exercised options | 7,998 | 20,124 | SEC | ||
| Jul 1, 2022 | Jul 6, 2022 | IONS | Director | AwardedNon-Qualified Stock Option (right to buy) | 17,333 | 15,108 | SEC | ||
| Nov 30, 2021 | Feb 14, 2022 | IONS | Director | GiftNon-Qualified Stock Option (right to buy) | 152,000 | 8,000 | SEC | ||
| Nov 30, 2021 | Feb 14, 2022 | IONS | Director | Gift | 12,000 | 6,000 | SEC | ||
| Jul 15, 2021 | Jul 19, 2021 | IONS | Director | Sold | 4,334 | $35.30 | $153k | 18,126 | SEC |
| Jul 15, 2021 | Jul 19, 2021 | IONS | Director | Exercised or settledRestricted Stock Unit | 8,666 | 9,775 | SEC | ||
| Jul 15, 2021 | Jul 19, 2021 | IONS | Director | Exercised options | 8,666 | 22,460 | SEC | ||
| Jul 1, 2021 | Jul 6, 2021 | IONS | Director | AwardedNon-Qualified Stock Option (right to buy) | 17,333 | 18,441 | SEC | ||
| Oct 20, 2020 | Oct 22, 2020 | IONS | Director | Sold | 2,889 | $46.86 | $135k | 13,794 | SEC |
| Oct 12, 2020 | Oct 13, 2020 | AKCEA THERAPEUTICS, INC. | Director | Returned to the companyStock Option (right to buy) | 26,400 | $2.01 | $53k | 0 | SEC |
| Jul 6, 2020 | Jul 6, 2020 | IONS | Director | Exercised or settledRestricted Stock Units | 4,000 | 666 | SEC | ||
| Jul 6, 2020 | Jul 6, 2020 | IONS | Director | Exercised options | 4,000 | 16,683 | SEC | ||
| Jul 1, 2020 | Jul 6, 2020 | IONS | Director | AwardedRestricted Stock Units | 17,333 | 12,000 | SEC |
Page 1
Sales and notices (65)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jul 1, 2026 | Jul 6, 2026 | IONS | Director | Form 4 sale | 11,518 | $910k | 51.1% | Routine | SEC |
| Jul 1, 2026 | Jul 1, 2026 | IONS | Director | Form 144 notice | 11,518 | $910k | Notice | SEC | |
| May 1, 2026 | May 5, 2026 | IONS | Director | Form 4 sale | 10,111 | $743k | 47.9% | Routine | SEC |
| Apr 1, 2026 | Apr 2, 2026 | IONS | Director | Form 4 sale | 22,321 | $1.7M | 67.0% | Routine | SEC |
| Mar 3, 2026 | Mar 5, 2026 | IONS | Director | Form 4 sale | 21,332 | $1.7M | 65.9% | Routine | SEC |
| Mar 3, 2026 | Mar 3, 2026 | IONS | Director | Form 144 notice | 65,345 | $5M | Notice | SEC | |
| Nov 25, 2025 | Nov 28, 2025 | IONS | Director | Form 4 sale | 12,000 | $960k | 100.0% | Routine | SEC |
| Nov 25, 2025 | Nov 25, 2025 | IONS | Director | Form 144 notice | 12,000 | $960k | Notice | SEC | |
| Sep 3, 2025 | Sep 4, 2025 | IONS | Director | Form 4 sale | 28,000 | $1.7M | 100.0% | Unusual | SEC |
| Sep 3, 2025 | Sep 4, 2025 | IONS | Director | Form 4 sale | 28,000 | $1.7M | 100.0% | Unusual | SEC |
| Sep 3, 2025 | Sep 3, 2025 | IONS | Director | Form 144 notice | 28,000 | $1.7M | Notice | SEC | |
| Jul 16, 2024 | Jul 17, 2024 | IONS | Director | Form 4 sale | 12,000 | $600k | 100.0% | Unusual | SEC |
| Jul 16, 2024 | Jul 16, 2024 | IONS | Director | Form 144 notice | 12,000 | $600k | Notice | SEC | |
| May 3, 2024 | May 7, 2024 | IONS | Director | Form 4 sale | 6,000 | $256k | 100.0% | Unusual | SEC |
| May 3, 2024 | May 3, 2024 | IONS | Director | Form 144 notice | 6,000 | $261k | Notice | SEC | |
| Nov 15, 2023 | Nov 17, 2023 | IONS | Director | Form 4 sale | 2,000 | $100k | 10.9% | Routine | SEC |
| Nov 15, 2023 | Nov 15, 2023 | IONS | Director | Form 144 notice | 2,000 | $100k | Notice | SEC | |
| Sep 26, 2023 | Sep 28, 2023 | IONS | Director | Form 4 sale | 2,000 | $90k | 9.8% | Routine | SEC |
| Sep 26, 2023 | Sep 26, 2023 | IONS | Director | Form 144 notice | 2,000 | $90k | Notice | SEC | |
| Jul 19, 2023 | Jul 19, 2023 | IONS | Director | Form 144 notice | 3,555 | $149k | Notice | SEC | |
| Jul 18, 2023 | Jul 19, 2023 | IONS | Director | Form 4 sale | 3,555 | $149k | 14.9% | No plan | SEC |
| Jan 17, 2023 | Jan 18, 2023 | IONS | Director | Form 4 sale | 2,000 | $80k | 10.6% | Plan not stated | SEC |
| Jul 15, 2022 | Jul 19, 2022 | IONS | Director | Form 4 sale | 1,333 | $51k | 6.6% | Plan not stated | SEC |
| Jul 15, 2021 | Jul 19, 2021 | IONS | Director | Form 4 sale | 4,334 | $153k | 19.3% | Unusual | SEC |
| Oct 20, 2020 | Oct 22, 2020 | IONS | Director | Form 4 sale | 2,889 | $135k | 17.3% | Plan not stated | SEC |
| Dec 23, 2019 | Dec 23, 2019 | IONS | Director | Form 4 sale | 1,000 | $62k | 7.3% | Plan not stated | SEC |
| Dec 16, 2019 | Dec 18, 2019 | IONS | Director | Form 4 sale | 1,000 | $65k | 7.3% | Plan not stated | SEC |
| Dec 9, 2019 | Dec 10, 2019 | IONS | Director | Form 4 sale | 1,000 | $64k | 7.3% | Plan not stated | SEC |
| Dec 2, 2019 | Dec 4, 2019 | IONS | Director | Form 4 sale | 1,000 | $64k | 7.3% | Plan not stated | SEC |
| Nov 25, 2019 | Nov 26, 2019 | IONS | Director | Form 4 sale | 812 | $51k | 6.0% | Plan not stated | SEC |
| Nov 20, 2019 | Nov 21, 2019 | IONS | Director | Form 4 sale | 2,000 | $120k | 12.9% | Plan not stated | SEC |
| Mar 29, 2018 | Mar 30, 2018 | IONS | Director | Form 4 sale | 2,000 | $92k | 16.8% | Plan not stated | SEC |
| Mar 15, 2018 | Mar 16, 2018 | IONS | Director | Form 4 sale | 2,000 | $102k | 16.8% | Plan not stated | SEC |
| Feb 28, 2018 | Mar 1, 2018 | IONS | Director | Form 4 sale | 3,000 | $156k | 23.2% | Plan not stated | SEC |
| Feb 15, 2018 | Feb 16, 2018 | IONS | Director | Form 4 sale | 3,000 | $147k | 23.2% | Plan not stated | SEC |
| Jan 16, 2018 | Jan 17, 2018 | IONS | Director | Form 4 sale | 3,000 | $158k | 23.2% | Plan not stated | SEC |
| Dec 29, 2017 | Jan 2, 2018 | IONS | Director | Form 4 sale | 3,000 | $152k | 23.2% | Plan not stated | SEC |
| Dec 15, 2017 | Dec 19, 2017 | IONS | Director | Form 4 sale | 3,000 | $155k | 23.2% | Plan not stated | SEC |
| Nov 30, 2017 | Dec 1, 2017 | IONS | Director | Form 4 sale | 3,000 | $161k | 23.2% | Plan not stated | SEC |
| Nov 15, 2017 | Nov 17, 2017 | IONS | Director | Form 4 sale | 2,250 | $121k | 24.0% | Plan not stated | SEC |
| Nov 13, 2017 | Nov 14, 2017 | IONS | Director | Form 4 sale | 3,000 | $166k | 29.6% | Unusual | SEC |
| Nov 11, 2015 | Nov 12, 2015 | IONS | Director | Form 4 sale | 6,875 | $441k | 55.4% | Unusual | SEC |
| Mar 5, 2015 | Mar 9, 2015 | IONS | Director | Form 4 sale | 7,000 | $497k | 63.1% | Unusual | SEC |
| Jan 24, 2014 | Jan 24, 2014 | IONS | Director | Form 4 sale | 10,313 | $502k | 81.7% | Unusual | SEC |
| Nov 25, 2013 | Nov 27, 2013 | IONS | Director | Form 4 sale | 6,000 | $221k | 72.2% | Unusual | SEC |
| Aug 9, 2013 | Aug 13, 2013 | IONS | Director | Form 4 sale | 18,750 | $529k | 69.3% | Unusual | SEC |
| Mar 20, 2013 | Mar 21, 2013 | IONS | Director | Form 4 sale | 3,924 | $71k | 100.0% | Unusual | SEC |
| Mar 20, 2013 | Mar 21, 2013 | IONS | Director | Form 4 sale | 42,776 | $770k | 100.0% | Unusual | SEC |
| Mar 13, 2013 | Mar 14, 2013 | IONS | Director | Form 4 sale | 20,800 | $375k | 100.0% | Unusual | SEC |
| Mar 8, 2010 | Mar 10, 2010 | BMRN | Director | Form 4 sale | 10,000 | $221k | 22.2% | Plan not stated | SEC |
Showing the first 50